San Francisco seed-stage fund Refactor Capital, founded David Lee of SV Angel and Zal Bilimoria of Andreessen Horowitz, announced earlier this week the close of its second fund at $30 million, according to a regulatory filing, which said the funding was raised by 37 backers.
As part of the fund close, the early-stage firm announced that Bilimoria will become sole GP as Lee moves to a chairman role.
The firm says it invests in such areas as “synthetic biology, consumer wellness, chemicals, computational drug discovery, consumer biology, as well as other fundamental human problems in areas such as aerospace, agriculture, and transportation.”
Source: Medium blog post
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.